Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Carbamic Acid 3-(4-((4-amino-5-chloro-2-methoxybenzoylamino)methyl)piperidin-1-yl)-1-(4-fluorophenyl)propyl Ester
2. Ykp10811
1. 1221416-43-8
2. Sis5bfo4wl
3. Ykp10811
4. Ykp-10811
5. (s)-(3-(4-(((4-amino-5-chloro-2-methoxybenzoyl)amino)methyl)piperidin-1- Yl)-1-(4-fluorophenyl)propyl) Carbamate
6. Unii-sis5bfo4wl
7. Relenopride [usan:inn]
8. Ykp 10811
9. Relenopride [inn]
10. Relenopride (usan/inn)
11. Relenopride [usan]
12. Relenopride [who-dd]
13. Gtpl8427
14. Schembl2335988
15. Chembl3544975
16. Dtxsid50153530
17. Db12798
18. [(1s)-3-[4-[[(4-amino-5-chloro-2-methoxybenzoyl)amino]methyl]piperidin-1-yl]-1-(4-fluorophenyl)propyl] Carbamate
19. D11220
20. Q27088530
21. (1s)-3-(4-((4-amino-5-chloro-2-methoxybenzamido)methyl)piperidin-1-yl)-1-(4-fluorophenyl)propyl Carbamate
22. Benzamide, 4-amino-n-((1-((3s)-3-((aminocarbonyl)oxy)-3-(4-fluorophenyl)propyl)-4-piperidinyl)methyl)-5-chloro-2-methoxy-
| Molecular Weight | 493.0 g/mol |
|---|---|
| Molecular Formula | C24H30ClFN4O4 |
| XLogP3 | 3.2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 10 |
| Exact Mass | 492.1939613 g/mol |
| Monoisotopic Mass | 492.1939613 g/mol |
| Topological Polar Surface Area | 120 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 659 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
65
PharmaCompass offers a list of Relenopride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Relenopride manufacturer or Relenopride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Relenopride manufacturer or Relenopride supplier.
PharmaCompass also assists you with knowing the Relenopride API Price utilized in the formulation of products. Relenopride API Price is not always fixed or binding as the Relenopride Price is obtained through a variety of data sources. The Relenopride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Relenopride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Relenopride, including repackagers and relabelers. The FDA regulates Relenopride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Relenopride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Relenopride supplier is an individual or a company that provides Relenopride active pharmaceutical ingredient (API) or Relenopride finished formulations upon request. The Relenopride suppliers may include Relenopride API manufacturers, exporters, distributors and traders.
Relenopride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Relenopride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Relenopride GMP manufacturer or Relenopride GMP API supplier for your needs.
A Relenopride CoA (Certificate of Analysis) is a formal document that attests to Relenopride's compliance with Relenopride specifications and serves as a tool for batch-level quality control.
Relenopride CoA mostly includes findings from lab analyses of a specific batch. For each Relenopride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Relenopride may be tested according to a variety of international standards, such as European Pharmacopoeia (Relenopride EP), Relenopride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Relenopride USP).
